|
Based
on PET results, the patient was restaged as
IIIs. Due to the extent and bulk of the disease,
the patient underwent an aggressive chemotherapy
regime. In this patient, PET scanning resulted
in a more accurate assessment of disease extent.
She was upstaged from stage II to stage IIIs
and her therapy was altered.
PET
evaluation of lymphoma typically results in
staring changes in nearly 25% of patients.
|